Nobumichi Tanaka

48PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersCancer cell biologyNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Aug 14, 2026
Sequential Enzalutamide-Docetaxel Versus Abiraterone-Docetaxel Therapy in Castration-Resistant Prostate Cancer: A Subanalysis of the ENABLE Study.

|Aug 01, 2026
Comparative outcomes of open, laparoscopic, and robot-assisted radical cystectomy using IPTW-adjusted trifecta and pentafecta metrics.

|Jul 16, 2026
Evaluating Risk Factors Associating With Late Recurrence After Low-Dose-Rate Brachytherapy for Prostate Cancer Using Machine Learning.

|Jul 02, 2026
The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC.

|Jun 04, 2026
Sarcopenia Weakens the Benefit of Bacillus Calmette-Guérin in Non-Muscle-Invasive Bladder Cancer: A Computed Tomography-Based Cohort Study.

|May 20, 2026
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa.

Pageof 8

Frequent Collaborators

33 joint publications

Makito Miyake

20 joint publications

Yasushi Nakai

17 joint publications

Shunta Hori

16 joint publications

Kiyohide Fujimoto